Home > Balance Sheet > CORONA REMEDIES

CORONA REMEDIES
Balance Sheet

CORONA REMEDIES is part of below Screeners ↓
Best 1M Momentum Small Cap Stocks
COMMUNITY POLL
for CORONA REMEDIES
Please provide your vote to see the results

CORONA REMEDIES Last 5 Year Balance Sheet History

[Consolidated]

Mar2026Mar2025Mar2024Mar2023
EQUITY AND LIABILITIES
Share Capital ₹61 Cr₹61 Cr₹61 Cr₹61 Cr
    Equity - Authorised ₹61 Cr₹61 Cr₹61 Cr₹61 Cr
    Equity - Issued ₹61 Cr₹61 Cr₹61 Cr₹61 Cr
    Equity Paid Up ₹61 Cr₹61 Cr₹61 Cr₹61 Cr
    Equity Shares Forfeited ----
    Adjustments to Equity ----
    Preference Capital Paid Up ----
    Face Value ₹10.00₹10.00₹10.00₹10.00
Share Warrants & Outstandings ----
Total Reserves ₹686 Cr₹545 Cr₹419 Cr₹347 Cr
    Securities Premium ₹42 Cr₹42 Cr₹42 Cr₹42 Cr
    Capital Reserves ----
    Profit & Loss Account Balance ₹644 Cr₹504 Cr₹378 Cr₹306 Cr
    General Reserves ----
    Other Reserves ----
Reserve excluding Revaluation Reserve ₹686 Cr₹545 Cr₹419 Cr₹347 Cr
Revaluation reserve ----
Shareholder's Funds ₹747 Cr₹606 Cr₹480 Cr₹409 Cr
Minority Interest ----
Long-Term Borrowings ----
Secured Loans -₹16 Cr₹67 Cr-
    Non Convertible Debentures ----
    Converible Debentures & Bonds ----
    Packing Credit - Bank ----
    Inter Corporate & Security Deposit ----
    Term Loans - Banks -₹16 Cr₹67 Cr-
    Term Loans - Institutions ----
    Other Secured ----
Unsecured Loans ----
    Fixed Deposits - Public ----
    Loans and advances from subsidiaries ----
    Inter Corporate Deposits (Unsecured) ----
    Foreign Currency Convertible Notes ----
    Long Term Loan in Foreign Currency ----
    Loans - Banks ----
    Loans - Govt. ----
    Loans - Others ----
    Other Unsecured Loan ----
Deferred Tax Assets / Liabilities ₹12 Cr₹8.30 Cr₹4.29 Cr₹-4.25 Cr
    Deferred Tax Assets ₹31 Cr₹23 Cr₹21 Cr₹18 Cr
    Deferred Tax Liability ₹43 Cr₹31 Cr₹25 Cr₹14 Cr
Other Long Term Liabilities ₹19 Cr₹21 Cr₹23 Cr₹24 Cr
Long Term Trade Payables ----
Long Term Provisions ₹66 Cr₹39 Cr₹32 Cr₹25 Cr
Total Non-Current Liabilities ₹97 Cr₹84 Cr₹126 Cr₹45 Cr
Current Liabilities ----
Trade Payables ₹147 Cr₹144 Cr₹114 Cr₹94 Cr
    Sundry Creditors ₹147 Cr₹144 Cr₹114 Cr₹94 Cr
    Acceptances ----
    Due to Subsidiaries- Trade Payables ----
Other Current Liabilities ₹46 Cr₹52 Cr₹50 Cr₹18 Cr
    Bank Overdraft / Short term credit ----
    Advances received from customers ₹0.68 Cr₹0.59 Cr₹1.13 Cr₹1.26 Cr
    Interest Accrued But Not Due ₹0.05 Cr₹0.47 Cr-₹0.03 Cr
    Share Application Money ----
    Current maturity of Debentures & Bonds ----
    Current maturity - Others ----
    Other Liabilities ₹45 Cr₹51 Cr₹49 Cr₹17 Cr
Short Term Borrowings ₹127 Cr₹11 Cr₹31 Cr₹2.33 Cr
    Secured ST Loans repayable on Demands ₹127 Cr₹11 Cr₹31 Cr₹2.33 Cr
    Working Capital Loans- Sec ₹127 Cr₹11 Cr₹31 Cr₹2.33 Cr
    Buyers Credits - Unsec ----
    Commercial Borrowings- Unsec ----
    Other Unsecured Loans ₹-127 Cr₹-11 Cr₹-31 Cr₹-2.33 Cr
Short Term Provisions ₹135 Cr₹121 Cr₹73 Cr₹94 Cr
    Proposed Equity Dividend ----
    Provision for Corporate Dividend Tax ----
    Provision for Tax ₹102 Cr₹94 Cr₹49 Cr₹76 Cr
    Provision for post retirement benefits ----
    Preference Dividend ----
    Other Provisions ₹33 Cr₹27 Cr₹24 Cr₹18 Cr
Total Current Liabilities ₹455 Cr₹327 Cr₹269 Cr₹209 Cr
Total Liabilities ₹1,299 Cr₹1,017 Cr₹875 Cr₹663 Cr
ASSETS
Gross Block ₹724 Cr₹503 Cr₹483 Cr₹256 Cr
Less: Accumulated Depreciation ₹170 Cr₹133 Cr₹99 Cr₹72 Cr
Less: Impairment of Assets ----
Net Block ₹554 Cr₹370 Cr₹384 Cr₹185 Cr
Lease Adjustment A/c ----
Capital Work in Progress ₹143 Cr₹186 Cr₹121 Cr₹65 Cr
Non Current Investments ₹26 Cr₹26 Cr₹26 Cr₹26 Cr
Long Term Investment ₹26 Cr₹26 Cr₹26 Cr₹26 Cr
    Quoted ₹0.16 Cr₹0.10 Cr₹0.07 Cr₹0.06 Cr
    Unquoted ₹26 Cr₹26 Cr₹25 Cr₹25 Cr
Long Term Loans & Advances ₹4.75 Cr₹9.10 Cr₹8.56 Cr₹9.54 Cr
Other Non Current Assets ₹129 Cr₹0.10 Cr₹2.27 Cr₹15 Cr
Total Non-Current Assets ₹857 Cr₹591 Cr₹541 Cr₹299 Cr
Current Assets Loans & Advances ----
Currents Investments ---₹5.97 Cr
    Quoted ---₹5.97 Cr
    Unquoted ----
Inventories ₹125 Cr₹129 Cr₹98 Cr₹105 Cr
    Raw Materials ₹27 Cr₹26 Cr₹19 Cr₹26 Cr
    Work-in Progress ₹7.38 Cr₹9.22 Cr₹6.52 Cr₹5.87 Cr
    Finished Goods ₹31 Cr₹33 Cr₹32 Cr₹30 Cr
    Packing Materials ₹6.10 Cr₹5.55 Cr₹5.04 Cr₹6.46 Cr
    Stores  and Spare ₹1.16 Cr₹0.45 Cr₹0.16 Cr₹0.07 Cr
    Other Inventory ₹52 Cr₹56 Cr₹35 Cr₹37 Cr
Sundry Debtors ₹146 Cr₹118 Cr₹100 Cr₹87 Cr
    Debtors more than Six months ₹1.96 Cr₹0.77 Cr₹0.44 Cr₹1.43 Cr
    Debtors Others ₹144 Cr₹118 Cr₹100 Cr₹86 Cr
Cash and Bank ₹44 Cr₹69 Cr₹70 Cr₹77 Cr
    Cash in hand ₹0.08 Cr₹0.03 Cr₹0.03 Cr₹0.08 Cr
    Balances at Bank ₹42 Cr₹67 Cr₹68 Cr₹72 Cr
    Other cash and bank balances ₹1.70 Cr₹2.67 Cr₹1.70 Cr₹4.71 Cr
Other Current Assets ₹2.28 Cr₹6.89 Cr₹3.79 Cr₹3.03 Cr
    Interest accrued on Investments ----
    Interest accrued on Debentures ----
    Deposits with Government ----
    Interest accrued and or due on loans ----
    Prepaid Expenses ₹1.91 Cr₹3.70 Cr₹3.39 Cr₹2.76 Cr
    Other current_assets ₹0.37 Cr₹3.19 Cr₹0.40 Cr₹0.27 Cr
Short Term Loans and Advances ₹125 Cr₹102 Cr₹63 Cr₹85 Cr
    Advances recoverable in cash or in kind ₹3.80 Cr₹8.08 Cr₹7.21 Cr₹7.41 Cr
    Advance income tax and TDS ₹93 Cr₹88 Cr₹45 Cr₹72 Cr
    Amounts due from directors ----
    Due From Subsidiaries ----
    Inter corporate deposits ----
    Corporate Deposits ----
    Other Loans & Advances ₹28 Cr₹6.86 Cr₹11 Cr₹6.00 Cr
Total Current Assets ₹442 Cr₹426 Cr₹335 Cr₹363 Cr
Net Current Assets (Including Current Investments) ₹-13 Cr₹99 Cr₹66 Cr₹154 Cr
Miscellaneous Expenses not written off ----
Total Assets ₹1,299 Cr₹1,017 Cr₹875 Cr₹663 Cr
Contingent Liabilities ₹1.01 Cr---
Total Debt ₹143 Cr₹63 Cr₹134 Cr₹2.33 Cr
Book Value -99.1478.5566.80
Adjusted Book Value 122.1299.1478.5566.80

Compare Balance Sheet of peers of CORONA REMEDIES

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
CORONA REMEDIES ₹12,656.2 Cr 1% 15.4% NA Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹463,815.0 Cr 0.5% 6.2% 17.3% Stock Analytics
DIVIS LABORATORIES ₹192,678.0 Cr 4.7% 9% 7% Stock Analytics
TORRENT PHARMACEUTICALS ₹161,323.0 Cr -3.7% 7.2% 49.8% Stock Analytics
CIPLA ₹114,585.0 Cr -0.6% 5% -3.2% Stock Analytics
DR REDDYS LABORATORIES ₹101,067.0 Cr -1.9% -4.6% -2.8% Stock Analytics


CORONA REMEDIES Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
CORONA REMEDIES

1%

15.4%

NA
SENSEX

0.8%

1.8%

-6.5%


You may also like the below Video Courses